China Proposes Larger Penalties on Counterfeit Vaccine Makers
China Proposes Larger Penalties on Counterfeit Vaccine Makers
(Bloomberg) -- China is intensifying its crackdown on makers of ineffective vaccines by introducing heavier penalties and more stringent regulations.
Companies guilty of making or selling counterfeit vaccines can be fined between 15 to 30 times the value of the products involved, China News Service reported, citing the second draft of a new vaccine management law. That compares with a proposed five to 10 times the value of the goods in the first draft in November. The penalty will be capped at 30 million yuan ($4.5 million) for goods valued below a million yuan.
China is trying to restore faith in the country’s drug industry after consumers were left feeling outraged and panicked last summer by disclosures about Changsheng Bio-technology Co. and a second company selling ineffective vaccines. Changsheng was found to have produced and sold low-quality vaccines for infants and to have fabricated production and inspection data on a rabies vaccine.
Protesters picketed government offices and worried parents traveled to Hong Kong for foreign-made vaccines. The government later slapped a 9.1 billion yuan penalty on Changsheng.
Under the latest proposed draft, drug companies will also bear larger legal responsibilities if they fail to show they have the necessary permits or certificates, or maintain relevant data records. The draft also includes provisions to encourage and support the research, development and innovation of vaccines.
To contact Bloomberg News staff for this story: Jinshan Hong in Hong Kong at jhong214@bloomberg.net;Dandan Li in Beijing at dli395@bloomberg.net
To contact the editors responsible for this story: Shamim Adam at sadam2@bloomberg.net, Nicholas Reynolds, James Mayger
©2019 Bloomberg L.P.
With assistance from Bloomberg